Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 1997

View Archived Issues

ET antagonists from Warner-Lambert claimed for cerebrovascular disorders

MS&D describes tachykinin antagonists

Factor Xa inhibitors from 3-D

Antiischemic potassium channel activators described by BMS

3-D describes potent and selective thrombin inhibitors

MS&D discloses 5-HT1-like receptor agonists

Glutamate antagonists from Warner-Lambert

Pharmacokinetics and tissue distribution of TOP-53

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

FDA approves Columbia's Crinone

PAK-104P reverses both P-glycoprotein- and MRP-mediated MDR

Potent, selective, orally active tachykinin NK1 antagonist reported by Menarini

New hypoxic cytotoxin from Evanston Hospital

Cellegy: Q1 1997 highlights

Interneuron: Q2 1997 highlights

Connetics: Q1 1997 highlights

NeoRx: Q1 1997 highlights

Dusa: Q1 1997 highlights

FDA advisory committee recommends Roche's Xenical for weight loss

Cytogen updates stockholders

Elan to market Dainippon's zonisamide in North America

SmithKline Beechan to market Kissei's tranilast

Discovery licenses N-0923 transdermal patch to Yoshitomi

NeoPharm licenses broxuridine to BioChem Therapeutic

Innovative Technologies and Derma Sciences form strategic joint venture

Receptagen receives offer to merge from Generex

Cephalon and Chiron seek European approval of Myotrophin

BMS and RTI form anticancer alliance

Mouse model for idiopathic voiding disorders in humans

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...